Product
Help
Pricing
About
Jobs
Log in
Get started
Source
Add to collection
Canadian Hematology Today
Homepage:
cht.ojssites.com
ISSNs:
2816-5152,
2816-5160
Source type:
journal
Publisher:
Fully OA:
Yes
DOAJ:
No
OpenAlex ID:
S4387291071
Hemophagocytic Lymphohistiocytosis and Other Cytokine Storm Syndromes in Adults
2025
·
Mariam Goubran
, Luke Chen
·
Canadian Hematology Today
·
5
PDF
Myeloproliferative neoplasms in 2022
2022
·
Dawn Maze
·
Canadian Hematology Today
·
3
PDF
Rational Use of Immunoglobulin in Adult Patients with Secondary Hypogammaglobulinemia in the Setting of Hematologic Malignancy: A Canadian Perspective
2025
·
Oksana Prokopchuk-Gauk
, Kathryn Webert
, et al.
·
Canadian Hematology Today
·
1
PDF
Minimal Residual Disease in Myeloma in 2024: Where We are Today
2024
·
Alfredo De la Torre
, Ana-Florencia Ramírez Ibarguen
·
Canadian Hematology Today
·
1
PDF
Bispecific antibodies and chimeric antigen receptor (CAR) T-cell therapy for indolent lymphoma
2023
·
Isabelle Fleury
, Eva Laverdure
·
Canadian Hematology Today
·
1
PDF
Navigating challenging treatment decisions in relapsed and refractory multiple myeloma (RRMM)
2023
·
Martha Louzada
, Arleigh McCurdy
, et al.
·
Canadian Hematology Today
·
1
PDF
A review of the mechanism of action, safety, and efficacy of selinexor in multiple myeloma
2023
·
Christine Chen
, Paola Neri
·
Canadian Hematology Today
·
1
PDF
To transplant or not to transplant in multiple myeloma
2022
·
Richard LeBlanc
·
Canadian Hematology Today
·
1
PDF
Sequencing Therapies in Peripheral T-Cell Lymphoma
2026
·
Danyal Ladha
, Anca Prica
·
Canadian Hematology Today
PDF
Post CAR T-Cell Therapy Care: Monitoring and Toxicity Management
2026
·
Justine Lai
, Peng Wang
, et al.
·
Canadian Hematology Today
PDF
Front-line DLBCL Therapies in Canada in 2026: Biology Matters
2026
·
Jia Liu
, Nathalie Johnson
·
Canadian Hematology Today
PDF
Front-Line Management of Mantle Cell Lymphoma in Canada: A Practical, Risk-Adapted Approach
2026
·
Justin Desroches
, Diego Villa
·
Canadian Hematology Today
PDF
Relapsed Follicular Lymphoma in 2026: Evolving Treatment Strategies in the Canadian Context
2026
·
Mary-Margaret Keating
·
Canadian Hematology Today
PDF
Current Management of Relapsed or Refractory Classic Hodgkin Lymphoma in Canada
2026
·
Colin Stewart
, Robert Puckrin
·
Canadian Hematology Today
High-Risk Multiple Myeloma in 2026: Evolving Definitions and Therapeutic Options
2026
·
Andrew J. Cowan
, Kevin Song
, et al.
·
Canadian Hematology Today
PDF
Upfront Therapy for Non‑transplantable Multiple Myeloma in 2026: Decision‑making in an Increasingly Complex Therapeutic Landscape
2026
·
Rina Latscha
, Sita Bhella
·
Canadian Hematology Today
PDF
Is Continuous Therapy Becoming Finite? The Evolving Landscape of CLL Treatment in 2026
2026
·
Stephanie Craig
, Shannon Murphy
·
Canadian Hematology Today
PDF
Approach to Patients with Acute Myeloid Leukemia in First Relapse: A Practical Guide for Canadian Hematologists
2026
·
Cristiano Machado de Freitas
, Guillaume Richard-Carpentier
·
Canadian Hematology Today
Not All Bruton's Tyrosine Kinase Inhibitors are Created Equal: Pharmacologic Insights into the Efficacy, Resistance, and Safety of Covalent and Non-covalent BTK Inhibitors
2026
·
Giorgio Minotti
·
Canadian Hematology Today
Navigating Sequencing in Relapsed/Refractory Multiple Myeloma: Canadian Experts Discuss the Evidence and the Evolving Options
2026
·
Peter Anglin
, Paola Neri
, et al.
·
Canadian Hematology Today
PDF
Practical Management of Aggressive B-Cell Lymphomas with CD20×CD3 Bispecific Antibodies
2025
·
Christopher Lemieux
·
Canadian Hematology Today
PDF
New Developments in the Front‑line Treatment of Advanced Stage Classic Hodgkin Lymphoma: A Canadian Perspective
2025
·
Jowon L. Kim
, Kerry J. Savage
·
Canadian Hematology Today
PDF
Unique Toxicities of Novel Myeloma Therapies: Focus on Belantamab Mafodotin, Talquetamab, and Selinexor
2025
·
Jesse Shustik
·
Canadian Hematology Today
PDF
Double-Exposed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Clinical Approach and Management
2025
·
Robert Puckrin
·
Canadian Hematology Today
PDF
Front-line Treatment for Chronic Lymphocytic Leukemia in 2025: Finite Duration Versus Continuous Treatment
2025
·
Chathuri Abeyakoon
, Abi Vijenthira
·
Canadian Hematology Today
PDF
Show more works
View as search
Works count:
86
Citation count:
14
H-index:
2
I10-index:
2yr mean citedness:
0.146
Year
Topic
Type
